22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024
22nd Century Group, Inc. (XXII) will announce its 2024 first quarter results on May 15, 2024, with a live webcast featuring the chairman and CEO Larry Firestone and CFO Dan Otto. The company focuses on tobacco harm reduction for health and wellness. The webcast will include financial reviews, progress updates, and a Q&A session.
- None.
- None.
Mocksville, North Carolina--(Newsfile Corp. - May 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco company focused on tobacco harm reduction to improve health and wellness, will host a live webcast on Wednesday, May 15, 2024, at 8:00 AM ET to discuss its 2024 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
Following management's prepared remarks and slide presentation, the Company will host a Q&A session, during which management will accept questions from research analysts.
The live and archived webcast and slide presentation will be accessible on the Events web page in the Company's Investor Relations section of the website, at https://ir.xxiicentury.com/events-and-presentations. Please access the website at least 15 minutes prior to the start of the webcast to register and, if necessary, download and install any required software.
About 22nd Century Group, Inc.
22nd Century Group, Inc. (NASDAQ: XXII) is a tobacco company focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness. With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the FDA's Comprehensive Plan to address the widespread death and disease caused by smoking. The Company received the first and only FDA Modified Risk Tobacco Product (MRTP) authorization for a combustible cigarette in December 2021. 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.
Learn more at xxiicentury.com, on Twitter, on LinkedIn, and on YouTube.
Learn more about VLN® at tryvln.com.
Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements, including but not limited to our full year business outlook. Forward-looking statements typically contain terms such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "explore," "foresee," "goal," "guidance," "intend," "likely," "may," "plan," "potential," "predict," "preliminary," "probable," "project," "promising," "seek," "should," "will," "would," and similar expressions. Actual results might differ materially from those explicit or implicit in forward-looking statements. Important factors that could cause actual results to differ materially are set forth in "Risk Factors" in the Company's Annual Report on Form 10-K filed on March 28, 2024. All information provided in this press release is as of the date hereof, and the Company assumes no obligation to and does not intend to update these forward-looking statements, except as required by law.
Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
mkreps@xxiicentury.com
214-597-8200
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/208204
FAQ
When will 22nd Century Group (XXII) announce its first quarter 2024 results?
Who will be hosting the live webcast to discuss the first quarter results?
What is the focus of 22nd Century Group (XXII) in terms of tobacco?
Where can the live and archived webcast be accessed?
How can one participate in the Q&A session during the webcast?
